ABSTRACT
Denvaxia is the first licensed vaccine for the prevention of dengue. It is a live vaccine developed using recombinant DNA technology. The vaccine is given as three doses over the course of a year and has the potential to prevent hundreds of thousands of hospitalizations each year.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Dengue
/
Vacinas contra Dengue
Limite:
Humans
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article